New Meningococcal B vaccine programme
Introduction of MenB time-limited vaccine programme
From 20 July 2026 the Meningococcal B (MenB) vaccine should be offered to those in the current year 13 age group, and eligible higher and further education entrants aged under 25 years for the 2026 to 2027 academic year. The MenB vaccination programme was introduced following the unprecedented outbreak of MenB in March 2026 and more recently.
What is MenB ?
Meningococcal group B (MenB) bacteria can cause serious, life-threatening illnesses including meningitis and septicaemia which can both lead to sepsis. Being around lots of new people in shared living spaces like university halls increases the risk of the bacteria that cause meningococcal disease spreading. Getting 2 doses of the MenB vaccine before the autumn term is one of the most important things young people can do to protect themselves.
How many doses are needed?
Two doses are essential for protection. The second dose should be given at least 28 days after the first, and it then takes a further 2 weeks for the body to build a good level of immunity. That means the whole process takes around 6 weeks from start to finish, which is why it’s important for those who are eligible to get a first dose as early as possible – ideally well before the autumn term begins.
What are the side effects of the vaccine?
Common side effects of the MenB vaccine are usually mild and do not last long and may include a fever, some swelling, redness or tenderness at the injection site, nausea, headache or muscle aches. These usually pass within a day or two. Over-the-counter pain relief such as paracetamol will help manage these symptoms. More serious side effects are rare.
How well does the MenB vaccine work?
The MenB vaccine covers most, but not all, strains of MenB that commonly cause disease in the UK. It has been routinely used in the UK infant vaccination programme since 2015 and in a study of babies showed a 75% reduction in MenB disease in vaccinated groups. It has been thoroughly tested and meets strict safety standards.
The MenB vaccine does not protect against all causes of meningitis and septicaemia nor against all strains of meningococcal bacteria. So, it remains important to be aware of signs and symptoms, the need to keep checking on those who are unwell and to seek early medical help if concerned about someone’s health.
How long does the protection offered by the MenB vaccine last?
Protection lasts for at least 5 years.
